Article ID Journal Published Year Pages File Type
3329221 Critical Reviews in Oncology/Hematology 2011 10 Pages PDF
Abstract

The present state of the art for management of patients with febrile neutropenia has been reviewed as well as potential ways to improve it in the future. A major advance has been the possibility to predict, accurately and early, the risk of complications and death in those patients. While the algorithm for therapy in low-risk patients is presently straightforward, significant progresses are needed for patients who are at higher risk of presenting severe complications.

Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
, , , ,